You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Advantages and disadvantages of the use of the CSF Amyloid β (Aβ) 42/40 ratio in the diagnosis of Alzheimer’s Disease
|
|---|---|
| Published in |
Alzheimer's Research & Therapy, April 2019
|
| DOI | 10.1186/s13195-019-0485-0 |
| Pubmed ID | |
| Authors |
Oskar Hansson, Sylvain Lehmann, Markus Otto, Henrik Zetterberg, Piotr Lewczuk |
X Demographics
The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Greece | 1 | 50% |
| Unknown | 1 | 50% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 2 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 398 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 398 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Ph. D. Student | 82 | 21% |
| Researcher | 40 | 10% |
| Student > Master | 38 | 10% |
| Student > Bachelor | 26 | 7% |
| Other | 24 | 6% |
| Other | 39 | 10% |
| Unknown | 149 | 37% |
| Readers by discipline | Count | As % |
|---|---|---|
| Neuroscience | 65 | 16% |
| Medicine and Dentistry | 41 | 10% |
| Biochemistry, Genetics and Molecular Biology | 31 | 8% |
| Pharmacology, Toxicology and Pharmaceutical Science | 15 | 4% |
| Psychology | 11 | 3% |
| Other | 67 | 17% |
| Unknown | 168 | 42% |
Attention Score in Context
This research output has an Altmetric Attention Score of 28. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 13 June 2023.
All research outputs
#1,278,074
of 23,857,313 outputs
Outputs from Alzheimer's Research & Therapy
#165
of 1,319 outputs
Outputs of similar age
#29,937
of 352,798 outputs
Outputs of similar age from Alzheimer's Research & Therapy
#5
of 32 outputs
Altmetric has tracked 23,857,313 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 94th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,319 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 26.8. This one has done well, scoring higher than 87% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 352,798 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 91% of its contemporaries.
We're also able to compare this research output to 32 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 87% of its contemporaries.